Oral fingolimod (FTY720) treatment reduces peripheral IL-17-producing TH17 cells in patients with multiple sclerosis

被引：0
|
作者：
Mehling, Matthias [1 ,2 ]
Lindberg, Raija L. [1 ,2 ]
Kuhle, Jens [1 ,2 ]
Vedrine, Corinne [3 ]
Kappos, Ludwig [1 ,2 ]
Brinkmann, Volker [3 ]
机构：
[1] Univ Basel Hosp, Dept Neurol, CH-4031 Basel, Switzerland
[2] Univ Basel Hosp, Dept Biomed, CH-4031 Basel, Switzerland
[3] Novartis Inst Biomed Res, Basel, Switzerland
来源：
MULTIPLE SCLEROSIS | 2008年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S234 / S234
页数：1
相关论文
共 50 条
  • [1] Th17 central memory T cells are reduced by FTY720 in patients with multiple sclerosis
    Mehling, M.
    Lindberg, R.
    Raulf, F.
    Kuhle, J.
    Hess, C.
    Kappos, L.
    Brinkmann, V.
    NEUROLOGY, 2010, 75 (05) : 403 - 410
  • [2] Oral fingolimod (FTY720) for relapsing multiple sclerosis
    Kappos, Ludwig
    Antel, Jack
    Comi, Giancarlo
    Montalban, Xavier
    O'Connor, Paul
    Polman, Chris H.
    Haas, Tomas
    Korn, Alexander A.
    Karlsson, Goeril
    Radue, Ernst W.
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (11): : 1124 - 1140
  • [3] Mechanism of Action of Oral Fingolimod (FTY720) in Multiple Sclerosis
    Chun, Jerold
    Hartung, Hans-Peter
    CLINICAL NEUROPHARMACOLOGY, 2010, 33 (02) : 91 - 101
  • [4] Fingolimod (Gileyna, FTY720): Innovative treatment for multiple sclerosis
    Pinki, Vijay Thawani
    JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS, 2011, 2 (03) : 206 - 206
  • [5] Fingolimod (FTY720): First approved oral therapy for multiple sclerosis
    Sharma, Sushil
    Mathur, A. G.
    Pradhan, Sapna
    Singh, D. B.
    Gupta, Sparsh
    JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS, 2011, 2 (01) : 49 - 51
  • [6] Fingolimod (Gileyna, FTY720): Innovative treatment for multiple sclerosis Reply
    Sharma, Sushil
    JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS, 2011, 2 (03) : 207 - 208
  • [7] Effect of fingolimod (FTY720) on choroidal thickness in patients with multiple sclerosis
    Kal, Ali
    Ulusoy, Mahmut Oguz
    Horasanli, Bahriye
    Cezairlioglu, Sefik
    Kal, Oznur
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2017, 14 : 4 - 7
  • [8] Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis
    Volker Brinkmann
    Andreas Billich
    Thomas Baumruker
    Peter Heining
    Robert Schmouder
    Gordon Francis
    Shreeram Aradhye
    Pascale Burtin
    Nature Reviews Drug Discovery, 2010, 9 : 883 - 897
  • [9] Inhibitory effect of corneal endothelial cells on IL-17-producing Th17 cells
    Sugita, Sunao
    Kawazoe, Yuko
    Yamada, Yukiko
    Imai, Ayano
    Horie, Shintaro
    Yamagami, Satoru
    Mochizuki, Manabu
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2012, 96 (02) : 293 - 299
  • [10] Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis
    Brinkmann, Volker
    Billich, Andreas
    Baumruker, Thomas
    Heining, Peter
    Schmouder, Robert
    Francis, Gordon
    Aradhye, Shreeram
    Burtin, Pascale
    NATURE REVIEWS DRUG DISCOVERY, 2010, 9 (11) : 883 - 897
12345